
Reset all filters
01 100ASTRAZENECA AB
02 396BOEHRINGER INGELHEIM
03 116JANSSEN PHARMS
04 26MSD SUB MERCK
05 1SANTARUS INC
06 1SUN PHARM
07 16TAKEDA PHARMS USA
Reset all filters
01 510022379*PED
02 1210258637*PED
03 410596120*PED
04 96515117
05 57326708
06 97407955
07 127579449
08 127713938
09 17780987
10 27785627
11 27807689
12 97919598
13 247943582
14 87943788
15 27959946
16 48080580
17 28173663
18 248222219
19 28288539
20 28414921
21 98501698
22 248513202
23 48551957
24 78628799
25 58673927
26 58685934
27 48716251
28 38846695
29 98883805
30 28900638
31 29101660
32 99155705
33 29173859
34 49308204
35 29320714
36 39339472
37 99415016
38 49439902
39 49555001
40 99616028
41 169949997
42 89949998
43 19962336
44 910022379
45 1210258637
46 410406172
47 1610596120
48 410610489
49 410610489*PED
50 310973827
51 310973827*PED
52 1211090323
53 1211090323*PED
54 311564886
55 411576894
56 811666590
57 411813275
58 411813275*PED
59 2411833166
60 1211833166*PED
61 511911388
62 1212115179
63 1212115179*PED
64 812263153
65 912364700
66 912364700*PED
67 96515117*PED
68 57326708*PED
69 97407955*PED
70 127579449*PED
71 127713938*PED
72 97919598*PED
73 87943582*PED
74 87943788*PED
75 88222219*PED
76 28414921*PED
77 98501698*PED
78 88513202*PED
79 48551957*PED
80 58673927*PED
81 58685934*PED
82 48716251*PED
83 38846695*PED
84 98883805*PED
85 59155705*PED
86 29173859*PED
87 59415016*PED
88 29555001*PED
89 99616028*PED
90 89949997*PED
91 89949998*PED
Reset all filters
01 121Y
02 535Blank
Reset all filters
01 222Y
02 434Blank
Reset all filters
01 22025-03-15
02 12025-03-23
03 242025-04-11
04 92025-05-02
05 22025-06-24
06 102025-07-13
07 92025-10-04
08 82025-10-11
09 92025-11-02
10 92025-11-26
11 92026-04-04
12 92026-05-26
13 42026-07-31
14 52026-11-24
15 22027-01-22
16 122027-04-15
17 72027-05-04
18 52027-05-24
19 92027-06-20
20 82027-07-14
21 122027-10-15
22 72027-11-04
23 242027-12-03
24 92027-12-20
25 82028-01-14
26 42028-03-21
27 82028-06-03
28 22028-06-27
29 22028-07-21
30 122028-08-01
31 42028-09-21
32 22029-01-21
33 122029-02-01
34 22029-02-03
35 242029-02-26
36 212029-04-02
37 22029-05-24
38 82029-08-26
39 132029-10-02
40 42029-10-14
41 92029-12-16
42 122030-02-11
43 52030-04-10
44 42030-04-14
45 92030-05-21
46 52030-05-26
47 32030-06-04
48 42030-06-15
49 92030-06-16
50 42030-07-06
51 42030-07-13
52 122030-08-11
53 42030-09-30
54 82030-10-21
55 92030-11-12
56 52030-11-21
57 52030-11-26
58 32030-12-04
59 42031-03-30
60 92031-05-12
61 192032-03-07
62 42032-09-07
63 42033-03-06
64 22033-09-06
65 682034-04-03
66 162034-05-17
67 82034-06-11
68 402034-10-03
69 82034-11-17
70 82034-12-11
71 12035-05-01
72 92037-06-08
73 92037-12-08
Patent Expiration Date : 2025-10-04
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 6515117
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 205649
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2025-10-04
Patent Expiration Date : 2025-10-04
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 6515117
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 205649
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2025-10-04
Patent Expiration Date : 2027-06-20
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8501698
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205649
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2027-06-20
Patent Expiration Date : 2025-10-04
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 6515117
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 205649
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2025-10-04
Patent Expiration Date : 2027-06-20
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8501698
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205649
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2027-06-20
Patent Expiration Date : 2030-05-26
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8685934
Drug Substance Claim :
Drug Product Claim :
Application Number : 205649
Patent Use Code : U-1522
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2030-05-26
Patent Expiration Date : 2025-10-04
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
US Patent Number : 6515117
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210874
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2025-10-04
Patent Expiration Date : 2025-10-04
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
US Patent Number : 6515117
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210874
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2025-10-04
Patent Expiration Date : 2027-06-20
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
US Patent Number : 8501698
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210874
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2027-06-20
Patent Expiration Date : 2027-06-20
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
US Patent Number : 8501698
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210874
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2027-06-20